Ependymoma Market Analysis: Current Landscape, Research Advances, and Future Opportunities
If you’ve been following developments in rare pediatric and CNS oncology, you’ve probably noticed that ependymoma is getting a lot more attention than it used to. This isn’t a coincidence. Better genomic tools, a clearer picture of the disease’s molecular subtypes, and a wave of new research investment are all converging at once. And that…
